ProShare Advisors LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$10,503
-4.4%
13,466
+33.6%
0.00%
Q1 2023$10,984
-37.1%
10,077
-15.8%
0.00%
Q4 2022$17,463
+34.3%
11,961
-1.0%
0.00%
Q3 2022$13,000
-27.8%
12,085
+12.7%
0.00%
Q2 2022$18,000
-37.9%
10,724
-24.5%
0.00%
Q1 2022$29,000
-59.7%
14,203
-26.5%
0.00%
Q4 2021$72,000
-52.3%
19,315
-34.0%
0.00%
Q3 2021$151,000
+45.2%
29,273
+19.4%
0.00%
Q2 2021$104,000
+4.0%
24,520
+30.1%
0.00%
Q1 2021$100,000
-11.5%
18,840
-10.3%
0.00%
Q4 2020$113,000
+232.4%
21,005
-6.6%
0.00%
Q3 2019$34,000
-64.6%
22,483
-5.8%
0.00%
-100.0%
Q2 2019$96,000
-17.9%
23,863
-12.5%
0.00%0.0%
Q1 2019$117,000
-21.5%
27,268
+5.1%
0.00%0.0%
Q4 2018$149,000
-59.4%
25,944
-4.2%
0.00%
-50.0%
Q3 2018$367,000
+11.9%
27,090
-1.9%
0.00%0.0%
Q2 2018$328,000
-2.7%
27,606
-8.0%
0.00%0.0%
Q1 2018$337,000
+60.5%
30,005
-4.7%
0.00%
+100.0%
Q4 2017$210,00031,4840.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$5,165,0004.93%
Long Focus Capital Management, LLC 4,429,491$9,125,0001.17%
Endurant Capital Management LP 2,160,890$4,451,0001.17%
NEA Management Company, LLC 17,082,611$35,190,0001.02%
Matrix Capital Management Company, LP 38,974,185$80,287,0000.96%
Key Client Fiduciary Advisors, LLC 420,447$866,0000.68%
ACT CAPITAL MANAGEMENT, LLC 90,000$185,0000.20%
DAFNA Capital Management LLC 351,064$723,0000.19%
PFM Health Sciences, LP 2,374,674$4,892,0000.18%
Rock Springs Capital Management LP 2,297,194$4,732,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders